Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Raw Materials (2021 - 2025)

Historic Raw Materials for Organogenesis Holdings (ORGO) over the last 5 years, with Q3 2025 value amounting to $14.1 million.

  • Organogenesis Holdings' Raw Materials rose 829.04% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 829.04%. This contributed to the annual value of $13.3 million for FY2024, which is 203.26% up from last year.
  • Organogenesis Holdings' Raw Materials amounted to $14.1 million in Q3 2025, which was up 829.04% from $13.9 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Raw Materials ranged from a high of $14.1 million in Q3 2025 and a low of $9.0 million during Q4 2021
  • Moreover, its 5-year median value for Raw Materials was $13.3 million (2024), whereas its average is $12.7 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Raw Materials soared by 3611.88% in 2022, and later crashed by 642.08% in 2024.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Raw Materials stood at $9.0 million in 2021, then soared by 36.12% to $12.3 million in 2022, then grew by 5.75% to $13.0 million in 2023, then increased by 2.03% to $13.3 million in 2024, then increased by 6.35% to $14.1 million in 2025.
  • Its last three reported values are $14.1 million in Q3 2025, $13.9 million for Q2 2025, and $13.9 million during Q1 2025.